Qualification for Cone-Optogenetics (EyeConic)
Status: Recruiting
Location: See all (9) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:
• Diagnosis of generalized IRD
• Low vision as defined as visual acuity worse or equal to 0.05 (or 20/400) in the study eye
• Availability of macular optical coherence tomography (OCT)
• Normal ophthalmic findings
• Availability of macular optical coherence tomography (OCT)
Locations
United States
California
University of California San Francisco, Department of Ophthalmology
RECRUITING
San Francisco
Florida
Bascom Palmer Eye Institute
RECRUITING
Miami
Pennsylvania
University of Pittsburgh, Department of Ophthalmology
RECRUITING
Pittsburgh
Other Locations
China
Beijing Institute of Ophthalmology
RECRUITING
Beijing
Germany
Universitätsklinikum Tübingen Augenklinik
RECRUITING
Tübingen
Hungary
Semmelweis University, Department of Ophthalmology
RECRUITING
Budapest
Italy
Oculista Ospedale Parma
RECRUITING
Parma
Switzerland
University Hospital Basel, Eye Clinic
RECRUITING
Basel
United Kingdom
Moorfields Eye Hospital
RECRUITING
London
Contact Information
Primary
Lucas Janeschitz-Kriegl, MD
lucas.janeschitz@iob.ch
+41787494373
Backup
Tiana Koottungal
tiana.koottungal@iob.ch
+41788486737
Time Frame
Start Date: 2021-07-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 1000
Treatments
Patients
-Availability of macular optical coherence tomography (OCT)
Controls
-Availability of macular optical coherence tomography (OCT)
Authors
Hendrik PN Scholl
Related Therapeutic Areas
Sponsors
Leads: Institute of Molecular and Clinical Ophthalmology Basel